Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Uterine Cervical Neoplasms 4Neoplasms 3Breast Neoplasms 3Papillomavirus Infections 2Lung Neoplasms 2Uterine Cervical Diseases 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Pulmonary Atelectasis 1Postural Orthostatic Tachycardia Syndrome 1Postoperative Complications 1Pneumonia 1Pancreatic carcinoma, familial 1Pancreatic cancer, adult 1Multiple Myeloma 1Mastocytosis 1Lung Cancer Screening 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1HIV Infections 1Financial Stress 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cervical Cancer Screening 1Bronchopulmonary Disease 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Dexamethasone 238Lenalidomide 145daratumumab 123Bortezomib 101pomalidomide 86Calcium Dobesilate 76carfilzomib 74Cyclophosphamide 70Specimen Handling 42isatuximab 40Biopsy 40fludarabine 36belantamab mafodotin 36Magnetic Resonance Spectroscopy 35talquetamab 29dexamethasone acetate 27dexamethasone 21-phosphate 27Melphalan 27auricularum 26iberdomide 25ixazomib 22fludarabine phosphate 22selinexor 21elotuzumab 21Whole-Body Irradiation 14X-Rays 13tocilizumab 12venetoclax 11Mycophenolic Acid 10trametinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × Mass Screening × 1 year × Clear all
NCT05844033 2026-05-19

Biomarker for Infection Risk in CLL and MM

Massachusetts General Hospital

Active not recruiting
150 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡